EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS

Marta Massano, Melani Nuñez-Montero, Esther Papaseit, Olga Hladun, Clara Pérez-Maña, Mireia Ventura, Emilia Marchei, Eugenio Alladio, Enrico Gerace, Simona Pichini, Magi Farrè, Alberto Salomone

Journal of Pharmaceutical and Biomedical Analysis · 2024

DOI: 10.1016/j.jpba.2024.115994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024. Verfasst von Marta Massano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Turin, Italy; Centro Regionale Antidoping, Orbassano, TO, Italy. Electronic address: arta.massano@unito.it. Hauptthemen laut MEDLINE: Synthetic Cathinone, Glucuronides, Methylamines, Propiophenones. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural cathinone, alkaloid present in the leaves of the Catha edulis (Khat) plant. These synthetic cathinones (SC) are members of the heterogenous family of new psychoactive substances (NPS) that raised major concerns in scientific and forensic communities over the past years due to their widespread consumption. In this context, we investigated their metabolic profile using of UHPLC-QTOF-HRMS to elucidate the distribution of the parent drug and its metabolites in urine samples over time. Initially, both male and female volunteers were divided into three groups and eight subjects of each group were administered intranasally or orally with one SC (20-40 mg of NEH or NEP intranasal, 100-150 mg of 4-CMC oral). Urine samples were collected at 0-2 and 2-4 or 2-5 h. Urine (50 μL) was diluted 1:2 with acetonitrile/methanol (95:5) and injected into the UHPLC-QTOF-HRMS. Phase-I and phase-II metabolites were identified on the basis of fragmentation patterns and exact masses. Several phase-I and glucuronide-phase-II metabolites were identified in urine samples. Keto group reduction, hydroxylation and dealkylation were the common metabolic pathways identified for all cathinones and the presence of NEH-glucuronide, NEP-glucuronide and 4-CMC-glucuronide was also relevant. Significant is the slower metabolite formation for 4-CMC, which was detected at high concentrations in its original form even 5 h after administration, due to its long half-life and low intrinsic clearance compared to the other SCs. UHPLC-QTOF-HRMS demonstrated a considerable capability to semi-quantify the three synthetic cathinones and identify the target metabolites with high reliability. The introduction of new target compounds improves the efficiency of toxicological screening analysis on real samples and extends the window of detection of the SCs in biological matrices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synthetic CathinoneGlucuronidesMethylaminesPropiophenonesHumansChromatography, High Pressure LiquidReproducibility of ResultsMetabolome

Stichwörter der Autor:innen

HRMSHuman urineMetabolitesNPSSynthetic cathinone

Substanzen

clephedroneSynthetic CathinoneGlucuronidesMethylaminesPropiophenones

Autor:innen und Institutionen

  • Department of Chemistry, University of Turin, Italy; Centro Regionale Antidoping, Orbassano, TO, Italy. Electronic address: arta.massano@unito.it.
  • Unit of Clinical Pharmacology Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP) and Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Energy Control, Associació Benestar i Desenvolupament, 08012 Barcelona, Spain.
  • National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Department of Chemistry, University of Turin, Italy; Centro Regionale Antidoping, Orbassano, TO, Italy.
  • Centro Regionale Antidoping, Orbassano, TO, Italy.

Zitieren

APA

Massano, M., Nuñez-Montero, M., Papaseit, E., Hladun, O., Pérez-Maña, C., Ventura, M., Marchei, E., Alladio, E., Gerace, E., Pichini, S., Farrè, M., & Salomone, A. (2024). Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.115994

Vancouver

Massano M, Nuñez-Montero M, Papaseit E, Hladun O, Pérez-Maña C, Ventura M, et al. Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS. Journal of Pharmaceutical and Biomedical Analysis. 2024. doi:10.1016/j.jpba.2024.115994

BibTeX
@article{Massano2024,
  author = {Massano, Marta and Nuñez-Montero, Melani and Papaseit, Esther and Hladun, Olga and Pérez-Maña, Clara and Ventura, Mireia and Marchei, Emilia and Alladio, Eugenio and Gerace, Enrico and Pichini, Simona and Farrè, Magi and Salomone, Alberto},
  title = {Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2024},
  doi = {10.1016/j.jpba.2024.115994}
}
Kostenlos starten →